What is S&L Therapy?
S&L Therapy, operating within the pediatric healthcare domain, focuses on providing specialized speech therapy services. The company's offerings are designed to support children from birth to 18 years old, addressing a wide spectrum of developmental needs including autism support, expressive and receptive language development, and feeding assistance. With a commitment to accountability and innovative treatment frameworks, S&L Therapy aims to enhance patient outcomes through specialized methodologies and dedicated training for its practitioners. The company's strategic late-stage funding indicates a mature operational phase, likely focused on scaling its established service model and potentially expanding its geographic reach or service portfolio.
How much funding has S&L Therapy raised?
S&L Therapy has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in S&L Therapy
PPP
Public-Private Partnership
What's next for S&L Therapy?
The substantial late-stage investment positions S&L Therapy for significant growth and strategic development. Future initiatives are likely to involve expanding clinic networks, enhancing technological integration for service delivery, and potentially exploring new therapeutic modalities. This capital infusion will enable the company to solidify its market leadership and pursue opportunities for further innovation in pediatric speech therapy, reinforcing its commitment to improving the lives of children and their families through specialized care.
See full S&L Therapy company page
